Versant Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $284K | Sell |
1,457
-413
| -22% | -$85.6K | 0.03% | 488 |
|
|
2026
Q1 | $420K | Buy |
1,870
+104
| +6% | +$25.9K | 0.04% | 319 |
|
|
2025
Q4 | $425K | Buy |
1,766
+37
| +2% | +$9.46K | 0.05% | 252 |
|
|
2025
Q3 | $473K | Buy |
1,729
+100
| +6% | +$27.3K | 0.06% | 219 |
|
|
2025
Q2 | $420K | Sell |
1,629
-47
| -3% | -$11.2K | 0.06% | 223 |
|
|
2025
Q1 | $375K | Buy |
1,676
+1,217
| +265% | +$284K | 0.06% | 224 |
|
|
2024
Q4 | $105K | Buy |
459
+183
| +66% | +$44.1K | 0.02% | 296 |
|
|
2024
Q3 | $67.4K | Buy |
276
+95
| +52% | +$21.2K | 0.02% | 348 |
|
|
2024
Q2 | $34.6K | Buy |
181
+120
| +197% | +$24.3K | 0.01% | 517 |
|
|
2024
Q1 | $12.1K | Hold |
61
| – | – | ﹤0.01% | 700 |
|
|
2023
Q4 | $10.5K | Buy |
61
+25
| +69% | +$3.84K | ﹤0.01% | 735 |
|
|
2023
Q3 | $5.32K | Sell |
36
-6
| -14% | -$1.08K | ﹤0.01% | 961 |
|
|
2023
Q2 | $9.18K | Buy |
42
+14
| +50% | +$3.12K | ﹤0.01% | 806 |
|
|
2023
Q1 | $6.11K | Hold |
28
| – | – | ﹤0.01% | 877 |
|
|
2022
Q4 | $5.83K | Hold |
28
| – | – | ﹤0.01% | 833 |
|
|
2022
Q3 | $6K | Hold |
28
| – | – | ﹤0.01% | 800 |
|
|
2022
Q2 | $6K | Hold |
28
| – | – | ﹤0.01% | 814 |
|
|
2022
Q1 | $7K | Hold |
28
| – | – | ﹤0.01% | 799 |
|
|
2021
Q4 | $7K | Hold |
28
| – | – | ﹤0.01% | 806 |
|
|
2021
Q3 | $7K | Sell |
28
-10
| -26% | -$2.73K | ﹤0.01% | 801 |
|
|
2021
Q2 | $9K | Hold |
38
| – | – | ﹤0.01% | 737 |
|
|
2021
Q1 | $7K | Hold |
38
| – | – | ﹤0.01% | 924 |
|
|
2020
Q4 | $8K | Hold |
38
| – | – | ﹤0.01% | 800 |
|
|
2020
Q3 | $6K | Hold |
38
| – | – | ﹤0.01% | 831 |
|
|
2020
Q2 | $7K | Hold |
38
| – | – | ﹤0.01% | 754 |
|
|
2020
Q1 | $5K | Hold |
38
| – | – | ﹤0.01% | 790 |
|
|
2019
Q4 | $5K | Buy |
38
+8
| +27% | +$1.15K | ﹤0.01% | 945 |
|
|
2019
Q3 | $4K | Sell |
30
-19
| -39% | -$2.49K | ﹤0.01% | 1029 |
|
|
2019
Q2 | $5K | Sell |
49
-48
| -49% | -$5.32K | ﹤0.01% | 970 |
|
|
2019
Q1 | $10K | Hold |
97
| – | – | ﹤0.01% | 910 |
|
|
2018
Q4 | $11K | Hold |
97
| – | – | 0.01% | 792 |
|
|
2018
Q3 | $11K | Hold |
97
| – | – | ﹤0.01% | 873 |
|
|
2018
Q2 | $10K | Hold |
97
| – | – | ﹤0.01% | 893 |
|
|
2018
Q1 | $9K | Sell |
97
-140
| -59% | -$13.2K | ﹤0.01% | 920 |
|
|
2017
Q4 | $20K | Hold |
237
| – | – | 0.01% | 660 |
|
|
2017
Q3 | $18K | Hold |
237
| – | – | 0.01% | 640 |
|
|
2017
Q2 | $18K | Hold |
237
| – | – | 0.01% | 637 |
|
|
2017
Q1 | $17K | Hold |
237
| – | – | 0.01% | 647 |
|
|
2016
Q4 | $14K | Buy |
237
+22
| +10% | +$1.35K | 0.01% | 715 |
|
|
2016
Q3 | $13K | Hold |
215
| – | – | 0.01% | 720 |
|
|
2016
Q2 | $13K | Hold |
215
| – | – | 0.01% | 695 |
|
|
2016
Q1 | $12K | Buy |
215
+140
| +187% | +$7.92K | 0.01% | 704 |
|
|
2015
Q4 | $4K | Buy |
+75
| New | +$4.23K | ﹤0.01% | 1003 |
|
Other funds holding RMD
AT
CIM
AC
MPWT
NAM
CNB
LTAS
Versant Capital Management's RMD Position: Q2 2026 in Review
Versant Capital Management reduced its ResMed (RMD) stake by 22% in Q2 2026, selling an estimated $85.6K and leaving 1,457 shares worth $284K. The position accounts for 0.03% of the portfolio, ranked #488.
Versant Capital Management first reported a position in RMD in Q4 2015 and has held it in 43 quarters since. The position peaked at $473K in Q3 2025. 124 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Versant Capital Management held 1,457 shares of ResMed worth $284K as of Q2 2026.
- Versant Capital Management sold 413 ResMed shares in Q2 2026, an estimated $85.6K.
- ResMed made up 0.03% of Versant Capital Management's portfolio in Q2 2026, its #488 holding.
- Versant Capital Management first reported a position in ResMed in Q4 2015 and has held it in 43 quarters since.
- Versant Capital Management's ResMed position peaked at $473K in Q3 2025.
- 124 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.